INGM Ingram Q4 2025 EPS beats consensus estimates shares climb nearly two percent on upbeat investor sentiment RGEN Repligen Corporation shares rise 46 percent after Q4 2025 EPS beats consensus estimates by 93 percent Vertex Pharmaceuticals VRTX Fundamental Deep Dive of a HighQuality Biotech Leader With MarketBeating Upside Moodys Corporation MCO Scheduled to Present at 18th Annual Barclays Americas Select Conference CFO to Lead Investor Remarks Studio MSC Business Model Review Marathon Petroleum Corporation MPC Q1 2026 Earnings Preview Mixed Fundamentals Amid Bearish Consensus Revision Headwinds Century Casinos CNTY Stock Future Outlook Analysis Century Casinos Posts 312 Negative EPS Surprise on Wider Loss American Tower Corporation AMT Mixed Brokerage Ratings Underscore Dividend Value and Undervalued Growth Catalysts What Geopark GPRK disclosed about crisis preparedness Q4 2025 Profit Exceeds Views SMTI Sanara MedTech climbs 25 percent in daily trading despite Q4 2025 EPS landing below analyst estimates